Join us on Thursday, May 7 @12-1 pm for a Faculty Talk w/Dr. Miguel Materin from Yale School of Medicine. This event will take place at the Hope Building, 315 Cedar Street, Room 103. Lunch will be provided. Sign up here.
Event Description:
Meet Dr. Miguel Materin: There are not many ophthalmologists that specialize in ocular cancer treatment. Miguel Materin, MD, Director of Ocular Oncology, is one of about 300 such physicians in the world and is internationally recognized ocular oncologist.
During this event, Dr. Materin will talk about his early days in Argentina, how he came to the US and his journey to Yale. He will also discuss important statistics on Cancer prevention and how it relates to the Latino community.
Sponsored by the Yale Cancer Center.
Biographical Info:
Dr. Materin joined the Yale University School of Medicine on January 1, 2009 as Director of Ophthalmic Oncology. He is an Associate Professor of Ophthalmology & Visual Science. His clinical practice involves diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. He has special interests in ocular melanoma, retinoblastoma, choroidal hemangiomas, retinal hemangioblastomas, metastases, astrocytic tumors and tumors related to other conditions or syndromes, like von Hippel Lindau disease, Tuberous Sclerosis among others. Dr. Materin is an internationally recognized ocular oncologist, serving as a member of the International Advisory Board (Ocular Oncology) for the Canadian Journal of Ophthalmology. He has published extensively in the peer-reviewed literature, including journals and book chapters. He has served as a visiting professor in US, Canada, Israel, Spain, Brazil, Puerto Rico, Argentina, and gave lectures worldwide. Dr. Materin has received the Achievement Award from the American Academy of Ophthalmology and he is a Member of Merit of Clinica Barraquer (Barcelona, Spain). He has served as Director of Diagnostic Studies at the Ocular Oncology Service at Wills Eye Hospital for 7 years. He is an active member of the International Society of Ocular Oncology, American Academy of Ophthalmology, Pan American Association of Ophthalmology and Argentine Society of Ophthalmology.